These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11848092)
21. Use of the polymerase chain reaction to monitor engraftment following allogeneic bone marrow transplantation. Chalmers EA; Sproul AM; Mills KI; Gibson BE; Burnett AK Bone Marrow Transplant; 1990 Dec; 6(6):399-403. PubMed ID: 2097008 [TBL] [Abstract][Full Text] [Related]
22. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361 [TBL] [Abstract][Full Text] [Related]
23. Cost of allogeneic bone marrow transplantation in four diseases. Viens-Bitker C; Fery-Lemonnier E; Blum-Boisgard C; Cordonnier C; Rochant H; Fischer A; Griscelli C; Gluckman E; Jolly D Health Policy; 1989; 12(3):309-17. PubMed ID: 10303779 [TBL] [Abstract][Full Text] [Related]
24. [Bone marrow autograft treated with mafosfamide in the acceleration phase in chronic myeloid leukemia. Inversion of the clinical development]. Fouillard L; Van Den Akker J; Laporte JP; Najman A; Perot C; Lopez M; Douay L; Isnard F; Taillemite JL; Gorin NC Presse Med; 1989 Nov; 18(36):1785-8. PubMed ID: 2530566 [TBL] [Abstract][Full Text] [Related]
25. [Treatment results of bone marrow transplantation in Kyushu Cancer Center. Bone Marrow Transplantation Team]. Tasaka H; Ikuno Y; Okamura J Rinsho Ketsueki; 1990 Mar; 31(3):315-9. PubMed ID: 2366334 [TBL] [Abstract][Full Text] [Related]
26. Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia. Fauser AA; Köchling G; Digel W; Finke J; Thiel M; Heinz J; Bross KJ; Dölken G; Mertelsmann R Bone Marrow Transplant; 1993; 11 Suppl 1():83. PubMed ID: 8448558 [No Abstract] [Full Text] [Related]
27. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937 [TBL] [Abstract][Full Text] [Related]
28. Bone marrow transplantation for chronic myeloid leukaemia. Goldman JM Bone Marrow Transplant; 1991; 7 Suppl 2():62-3. PubMed ID: 1878724 [No Abstract] [Full Text] [Related]
29. Diagnostic and therapeutic technology assessment. Allogeneic bone marrow transplantation for chronic myelogenous leukemia. JAMA; 1990 Dec; 264(24):3208-11. PubMed ID: 2255031 [No Abstract] [Full Text] [Related]
30. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Sawyers CL; Timson L; Kawasaki ES; Clark SS; Witte ON; Champlin R Proc Natl Acad Sci U S A; 1990 Jan; 87(2):563-7. PubMed ID: 2405384 [TBL] [Abstract][Full Text] [Related]
31. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia. Kohler S; Galili N; Sklar JL; Donlon TA; Blume KG; Cleary ML Leukemia; 1990 Aug; 4(8):541-7. PubMed ID: 2201832 [TBL] [Abstract][Full Text] [Related]
32. Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Sekhri A; Liu D; Rasul M; Ahmed N; Ahmed T; Seiter K Leuk Res; 2009 Sep; 33(9):1291-3. PubMed ID: 19344950 [TBL] [Abstract][Full Text] [Related]
33. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia. Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734 [TBL] [Abstract][Full Text] [Related]
34. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia. Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255 [TBL] [Abstract][Full Text] [Related]
35. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193 [TBL] [Abstract][Full Text] [Related]
36. How do transplants cure chronic myelogenous leukemia? Gale RP; Butturini A Bone Marrow Transplant; 1992 Feb; 9(2):83-5. PubMed ID: 1571713 [No Abstract] [Full Text] [Related]
37. Graft-versus-leukemia reactions following bone marrow transplantation for chronic myeloid leukemia. Mackinnon S Prog Clin Biol Res; 1992; 377():113-25; discussion 126-7. PubMed ID: 1438407 [No Abstract] [Full Text] [Related]
39. Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia. Drobyski WR; Pelz C; Kabler-Babbitt C; Hessner M; Baxter-Lowe LA; Keever-Taylor CA Biol Blood Marrow Transplant; 1998; 4(1):3-12. PubMed ID: 9701386 [TBL] [Abstract][Full Text] [Related]
40. Bone marrow transplantation for the treatment of chronic myelogenous leukemia. Fefer A; Thomas ED Important Adv Oncol; 1990; ():143-58. PubMed ID: 2182517 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]